Skip to main content

Zenyum

ServiceSingapore, SingaporeFounded 2018· One of 1986 Service companies tracked by AMPulse

A leading Asian dental technology company providing affordable 3D-printed clear aligners and a comprehensive portfolio of 'Smile Cosmetics' through a tech-enabled clinical network.

CEO / Founder
Julian Artopé
Team Size
201-500
Stage
Subsidiary
Total Funding
$56M
Latest Round
Series B
Key Investors
L Catterton, Peak XV Partners (formerly Sequoia India), RTP Global, Partech, TNB Aura, Seeds Capital, FEBE Ventures

Technology & Products

Key Products

Zenyum offers 3D-printed clear aligners, invisible clear aligners, and a comprehensive portfolio of oral care products under the "Smile Cosmetics" category.

Technological Advantage

Proprietary mobile app for remote treatment monitoring and AI-driven pre-screening, combined with a localized regional network of over 500 partner clinics and high-precision 3D printing (Polymer AM) manufacturing workflows.

Differentiation

Value Proposition

Delivers professional-grade orthodontic results at up to 70% lower cost than traditional braces by utilizing a proprietary tech stack to minimize clinic visits while maintaining dentist oversight.

How They Differentiate

Pioneered the 'Smile Cosmetics' category by blending professional orthodontic care with a lifestyle brand identity. Differentiates through a hybrid model that requires mandatory initial dentist consultations while utilizing a proprietary app for remote monitoring, offering treatments at 70% lower costs than traditional braces.

Market & Competition

Target Customers

The rising Asian middle class, specifically Gen Z and Millennials seeking accessible, aesthetic orthodontic treatments and premium oral care.

Industry Verticals

["HealthTech","Dental Care / Orthodontics","Direct-to-Consumer (D2C)","Consumer Goods (Personal Care)"]

Competitors

Invisalign, WonderSmile, Smile Direct Club, Dr Clear Aligners

Growth & Milestones

Growth Metrics

Reported a 4x revenue increase in 2020; achieved EBITDA profitability in its largest markets; 8-fold improvement in lead activation rates via AI-driven marketing automation.

Major Milestones

["Selected for Sequoia India's Surge accelerator program in 2019","Expanded operations to 7 Asian markets within three years of founding","Secured $40M Series B led by L Catterton in 2021","Announced strategic merger with India's MakeO (Toothsi) in 2024 to create Asia's largest clinical-tech dental platform","Merger with MakeO completed in February 2026, Zenyum becomes subsidiary of MakeO holding company"]

Notable Customers

Salesforce (Case Study); Primer (Case Study); Pokémon (Co-branding Partner); Shopee (Strategic Partner)

https://www.zenyum.com

Recent coverage of Zenyum

Why this company matters

Zenyum positions itself as a consumer-tech dental platform rather than a pure orthodontic provider, having pioneered the 'Smile Cosmetics' category that reframes dental care as a lifestyle choice. Founded in 2018, the company targets Gen Z and Millennials across Asia with affordable clear aligners and a branded oral care product line, competing against Invisalign, Smile Direct Club, and regional players like WonderSmile and Dr Clear Aligners.

The core service relies on VPP-SLA 3D printing to manufacture clear aligners in-house, supported by an AI-driven mobile app for remote treatment monitoring and pre-screening. Unlike fully direct-to-consumer models, Zenyum requires mandatory initial consultations at a network of over 500 licensed partner clinics across nine Asian markets, blending D2C convenience with professional oversight. The company also offers a broader portfolio of 'Smile Cosmetics' oral care products sold through e-commerce channels.

Zenyum's strategic moat lies in its hybrid clinical-tech model and regional scale. A 2024 merger with India's MakeO (Toothsi) created what the company claims is Asia's largest clinical-tech dental platform. Key partnerships include Salesforce and Shopee for customer engagement, Appier for AI-driven marketing automation, and INSEAD for professional development of partner dentists. The company reported a 4x revenue increase in 2020 and achieved EBITDA profitability in its largest markets, though the long-term competitive risk includes potential margin pressure from low-cost aligner entrants and the capital intensity of maintaining a physical clinic network.